DependenceNCT06006364
Investigation of the Effect of Nomophobia on Musculoskeletal System and Sleep
An observational study of Dependence, run by Uskudar University at 1 site in Turkey (Türkiye).
Trial summary
The aim of this study; Investigation of the effects on the musculoskeletal system and sleep by determining the nomophobia levels of individuals between the ages of 18-25. Read more about this study
- Who is it for?
- Ages 18 to 50 yearsHealthy volunteers can take part
- Conditions the study is for
- Dependence
- What is being tested?
- Survey
- How many people
- 200 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 1 Sep 2023to 6 Dec 2023
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 50 years
- All sexes
- Healthy volunteers accepted
- Adult
Study population: people with whom we were able to create the survey and who met the inclusion criteria
Who may be able to join
- To have accepted the voluntary consent form that requires participation in the survey study.
- Being a smart phone user
Who cannot join
- Not accepting the volunteer consent form
- Having undergone previous surgery
- Being on antidepressants.
Trial locations and contacts
1 site in 1 country.
About this study
The aim of this study; Investigation of the effects on the musculoskeletal system and sleep by determining the nomophobia levels of individuals between the ages of 18-25.
Read the detailed description
The research was planned as a quantitative research. Data collection was done online.
The scales and forms used are as follows:
- Demographic Information Form
- Nomophobia Scale
- Cornell Musculoskeletal Disorder Questionnaire
- Smart phone Addiction Scale
- Pittsburgh Sleep Quality Index
- International Physical Activity Survey
- McGill Melzack Pain Questionnaire
Questionnaires will be sent to the participants online by invitation. Participants will be asked to participate in the study by reaching them through social media, mail or mobile phone applications. The data obtained will be analyzed statistically.
- Conditions
- Dependence
- Being tested
- Survey
- Keywords
- nomophobia, sleep
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
SurveyOther
The scales and forms used are respectively:
- Demographic Information Form
- Nomophobia Scale
- Cornell Musculoskeletal Disorder Questionnaire
- Smart phone Addiction Scale
- Pittsburgh Sleep Quality Index
- International Physical Activity Survey
- McGill Melzack Pain Questionnaire
| Study group | Role | What they receive |
|---|---|---|
| 1.Group | Nomophobia Level:none Receives: Other: Survey | |
| 2.Group | Nomophobia Level: mild Receives: Other: Survey | |
| 3.Group | Nomophobia Level: medium Receives: Other: Survey | |
| 4.Group | Nomophobia Level: extreme Receives: Other: Survey |
What is being measured
The primary outcome is the main question the study is designed to answer.
Nomophobia Scale
The Nomophobia Scale was itemized according to a 7-point Likert type. Out of 20 items in total consists of. The scale has four sub-dimensions: Lack of Access to Information (4 items), Losing Connection (5 items), Inability to Communicate (6 items), and Comfort Inability to feel (5 items).
Measured: 2 days
Cornell Musculoskeletal Disorder Questionnaire
The questionnaire was conducted in 11 body regions (neck, right and left shoulder, upper arm, forearm and wrist, back and waist region) includes questions about the frequency of musculoskeletal disorders (pain/pain/discomfort), the severity of these disorders, and whether they interfere with work.
Measured: 2 days
Smart phone Addiction Scale
It is a scale developed to measure the risk of smart phone addiction, consisting of 10 items and evaluated with a six-point Likert scale. Scale items were scored from 1 to 6. Scale scores range from 10 to 60. As the score obtained from the test increases, it is considered that the risk for addiction increases.
Measured: 2 days
Pittsburgh Sleep Quality Index
It is a 19-item self-report scale that evaluates sleep quality and impairment over the past month. It consists of 24 questions, 19 questions are self-report questions, 5 questions are questions to be answered by the spouse or roommate. The 18 scored questions of the scale consist of 7 components. Subjective Sleep Quality, Sleep Latency, Sleep Duration, Habitual Sleep Efficiency, Sleep Disorder, Sleeping Drug Use and Daytime Dysfunction. Each component is evaluated over 0-3 points. The total score of the 7 components gives the scale total score. The total score ranges from 0 to 21. A total score greater than 5 indicates "poor sleep quality".
Measured: 2 days
International Physical Activity Questionnaire Short Form
The questionnaire consisting of seven questions including the activities of the last seven days was prepared by the individuals themselves.
self-applicable and provides information about the time people spend in moderate to vigorous activities
Measured: 2 days
McGill Melzack Pain Questionnaire
Pain Questionnaire consists of four parts. With the McGill Melzack Pain Questionnaire, the location of the pain, the feeling it creates in the individual, its relationship with time, its severity and the level of livable pain for the individual are determined.
Measured: 2 days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted23 Aug 2023
- Study start1 Sep 2023
- Primary completion2 Oct 2023
- Study completion6 Dec 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (5)Papers the sponsor has linked to this study.
- Other trials for DependenceStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Prospective
- Enrolment
- 200 participants (actual)
Sponsor and investigators
- Lead sponsor
- Uskudar University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Dr. Öğr. Üyesi Ömer Şevgin, Uskudar University
- Investigators
- Melek ÖZCAN, Study chair, Uskudar University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06006364
- Sponsor's protocol ID
- Uskudar55
- Status last verified
- Dec 2023
- First submitted
- 17 Aug 2023
- Last updated
- 7 Dec 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Bhattacharya S, Bashar MA, Srivastava A, Singh A. NOMOPHOBIA: NO MObile PHone PhoBIA. J Family Med Prim Care. 2019 Apr;8(4):1297-1300. doi: 10.4103/jfmpc.jfmpc_71_19.
PubMed 31143710Kuscu TD, Gumustas F, Rodopman Arman A, Goksu M. The relationship between nomophobia and psychiatric symptoms in adolescents. Int J Psychiatry Clin Pract. 2021 Mar;25(1):56-61. doi: 10.1080/13651501.2020.1819334. Epub 2020 Sep 17.
PubMed 32940094Notara V, Vagka E, Gnardellis C, Lagiou A. The Emerging Phenomenon of Nomophobia in Young Adults: A Systematic Review Study. Addict Health. 2021 Apr;13(2):120-136. doi: 10.22122/ahj.v13i2.309.
PubMed 34703533Rahme C, Hallit R, Akel M, Chalhoub C, Hachem M, Hallit S, Obeid S. Nomophobia and temperaments in Lebanon: Results of a national study. Perspect Psychiatr Care. 2022 Oct;58(4):1607-1612. doi: 10.1111/ppc.12968. Epub 2021 Nov 6.
PubMed 34741546Jahrami HA, Fekih-Romdhane F, Saif ZQ, Alhaj OA, AlRasheed MM, Pandi-Perumal SR, BaHammam AS, Vitiello MV. Sleep dissatisfaction is a potential marker for nomophobia in adults. Sleep Med. 2022 Oct;98:152-157. doi: 10.1016/j.sleep.2022.07.001. Epub 2022 Jul 11.
PubMed 35868112
Study at a glance
From the registry record, last updated by the sponsor on 7 Dec 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Investigation of the Effect of Nomophobia on Musculoskeletal System and Sleep
- ClinicalTrials.gov ID
- NCT06006364
- Acronym / sponsor ID
- Uskudar55
- Conditions
- Dependence
- Keywords
- nomophobia, sleep
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 200 participants (actual)
- Lead sponsor
- Uskudar UniversityUniversity, hospital or other
- Study start
- 1 Sep 2023 (actual)
- Primary completion
- 2 Oct 2023 (actual)
- Study completion
- 6 Dec 2023 (actual)
- First posted
- 23 Aug 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of this study; Investigation of the effects on the musculoskeletal system and sleep by determining the nomophobia levels of individuals between the ages of 18-25.
Detailed description
The research was planned as a quantitative research. Data collection was done online.
The scales and forms used are as follows:
- Demographic Information Form
- Nomophobia Scale
- Cornell Musculoskeletal Disorder Questionnaire
- Smart phone Addiction Scale
- Pittsburgh Sleep Quality Index
- International Physical Activity Survey
- McGill Melzack Pain Questionnaire
Questionnaires will be sent to the participants online by invitation. Participants will be asked to participate in the study by reaching them through social media, mail or mobile phone applications. The data obtained will be analyzed statistically.
Study design
- Observational model
- Other
- Time perspective
- Prospective
- Number of arms
- 4
| Arm | Type | Receives |
|---|---|---|
| 1.Group | – | Other: SurveyNomophobia Level:none |
| 2.Group | – | Other: SurveyNomophobia Level: mild |
| 3.Group | – | Other: SurveyNomophobia Level: medium |
| 4.Group | – | Other: SurveyNomophobia Level: extreme |
Who may qualify
- Ages
- 18 to 50 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
- Study population
- people with whom we were able to create the survey and who met the inclusion criteria
Key inclusion criteria (2 listed)
- To have accepted the voluntary consent form that requires participation in the survey study.
- Being a smart phone user
Key exclusion criteria (3 listed)
- Not accepting the volunteer consent form
- Having undergone previous surgery
- Being on antidepressants.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| SurveyThe scales and forms used are respectively: 1. Demographic Information Form 2. Nomophobia Scale 3. Cornell Musculoskeletal Disorder Questionnaire 4. Smart phone Addiction Scale 5. Pittsburgh Sleep Quality Index 6. International Physical Activity Survey 7. McGill Melzack Pain Questionnaire | Other | 1.Group, 2.Group, 3.Group, 4.Group |
Primary outcome
Nomophobia Scale
Time frame: 2 days
The Nomophobia Scale was itemized according to a 7-point Likert type. Out of 20 items in total consists of. The scale has four sub-dimensions: Lack of Access to Information (4 items), Losing Connection (5 items), Inability to Communicate (6 items), and Comfort Inability to feel (5 items).
Cornell Musculoskeletal Disorder Questionnaire
Time frame: 2 days
The questionnaire was conducted in 11 body regions (neck, right and left shoulder, upper arm, forearm and wrist, back and waist region) includes questions about the frequency of musculoskeletal disorders (pain/pain/discomfort), the severity of these disorders, and whether they interfere with work.
Smart phone Addiction Scale
Time frame: 2 days
It is a scale developed to measure the risk of smart phone addiction, consisting of 10 items and evaluated with a six-point Likert scale. Scale items were scored from 1 to 6. Scale scores range from 10 to 60. As the score obtained from the test increases, it is considered that the risk for addiction increases.
Pittsburgh Sleep Quality Index
Time frame: 2 days
It is a 19-item self-report scale that evaluates sleep quality and impairment over the past month. It consists of 24 questions, 19 questions are self-report questions, 5 questions are questions to be answered by the spouse or roommate. The 18 scored questions of the scale consist of 7 components. Subjective Sleep Quality, Sleep Latency, Sleep Duration, Habitual Sleep Efficiency, Sleep Disorder, Sleeping Drug Use and Daytime Dysfunction. Each component is evaluated over 0-3 points. The total score of the 7 components gives the scale total score. The total score ranges from 0 to 21. A total score greater than 5 indicates "poor sleep quality".
International Physical Activity Questionnaire Short Form
Time frame: 2 days
The questionnaire consisting of seven questions including the activities of the last seven days was prepared by the individuals themselves. self-applicable and provides information about the time people spend in moderate to vigorous activities
McGill Melzack Pain Questionnaire
Time frame: 2 days
Pain Questionnaire consists of four parts. With the McGill Melzack Pain Questionnaire, the location of the pain, the feeling it creates in the individual, its relationship with time, its severity and the level of livable pain for the individual are determined.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 7 Dec 2023.
- Background: PubMed 31143710Bhattacharya S, Bashar MA, Srivastava A, Singh A. NOMOPHOBIA: NO MObile PHone PhoBIA. J Family Med Prim Care. 2019 Apr;8(4):1297-1300. doi: 10.4103/jfmpc.jfmpc_71_19.
- Background: PubMed 32940094Kuscu TD, Gumustas F, Rodopman Arman A, Goksu M. The relationship between nomophobia and psychiatric symptoms in adolescents. Int J Psychiatry Clin Pract. 2021 Mar;25(1):56-61. doi: 10.1080/13651501.2020.1819334. Epub 2020 Sep 17.
- Background: PubMed 34703533Notara V, Vagka E, Gnardellis C, Lagiou A. The Emerging Phenomenon of Nomophobia in Young Adults: A Systematic Review Study. Addict Health. 2021 Apr;13(2):120-136. doi: 10.22122/ahj.v13i2.309.
- Background: PubMed 34741546Rahme C, Hallit R, Akel M, Chalhoub C, Hachem M, Hallit S, Obeid S. Nomophobia and temperaments in Lebanon: Results of a national study. Perspect Psychiatr Care. 2022 Oct;58(4):1607-1612. doi: 10.1111/ppc.12968. Epub 2021 Nov 6.
- Background: PubMed 35868112Jahrami HA, Fekih-Romdhane F, Saif ZQ, Alhaj OA, AlRasheed MM, Pandi-Perumal SR, BaHammam AS, Vitiello MV. Sleep dissatisfaction is a potential marker for nomophobia in adults. Sleep Med. 2022 Oct;98:152-157. doi: 10.1016/j.sleep.2022.07.001. Epub 2022 Jul 11.
- Individual participant dataSharing planned: No
Related trials for Dependence
Recruiting
Effectiveness of Volitional Help Sheets as an Adjunct to Treatment to Promote Behavior Change: A Pilot Study on Smoking
Tobacco Dependence
Active, not recruitingPhase 1
Psilocybin-assisted Treatment for Cannabis Use Disorder
Cannabis Use Disorder
Not yet recruiting
Effects of Virtual Reality-Based Optokinetic Stimulation Added to Neuromuscular Training in Basketball Players
Visual Dependence, Postural Control
Recruiting
Young Adult Tobacco/Nicotine and Cannabis Co-use
Tobacco Use Disorder, Nicotine Dependence
Recruiting
Social Media Support Groups for Adolescent Vaping Cessation
Vaping, Vaping Cessation
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Melek ÖZCAN study chair
Uskudar University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Dependence, run by Uskudar University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 7 Dec 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Nomophobia Scale (time frame: 2 days). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06006364, which also lists 5 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Dec 2023.